A semiquantitative assay for CD8+ T-cell-mediated suppression of human immunodeficiency virus type 1 infection

Y Chen1, C Rinaldo, P Gupta

  • 1Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health and School of Medicine, Pennsylvania 15261, USA.

Insights

A new assay quantifies CD8+ T cell anti-human immunodeficiency virus type 1 (HIV-1) activity. This reproducible method aids research into HIV-1 natural history, therapy, and vaccine efficacy.

Area of Science:

  • Immunology
  • Virology
  • Cellular Biology

Background:

  • CD8+ T cells play a crucial role in controlling viral infections, including human immunodeficiency virus type 1 (HIV-1).
  • Quantifying the suppressive activity of CD8+ T cells is essential for understanding HIV-1 pathogenesis and evaluating therapeutic interventions.
  • Existing methods may have limitations in sensitivity, dynamic range, or applicability to various sample types.

Purpose of the Study:

  • To develop and validate a reproducible, semiquantitative assay for measuring the anti-HIV-1 suppressive activity of CD8+ T cells.
  • To characterize the nature of the CD8+ T cell-mediated suppression.
  • To establish an assay applicable to both fresh and cryopreserved cells for broad utility.

Main Methods:

  • Development of a semiquantitative assay to measure CD8+ T cell suppressive activity against HIV-1.
  • Application of the assay to fresh and cryopreserved peripheral blood mononuclear cells (PBMCs) and purified CD8+ T cells.
  • Characterization of suppressive activity regarding cytolytic mechanisms and MHC class I restriction.

Main Results:

  • The assay demonstrated reproducibility and a wide dynamic range.
  • Suppressive activity could be measured using small numbers of fresh and cryopreserved cells.
  • The suppressive activity was independent of cytolytic activity and MHC class I restriction.
  • Consistent suppression was observed with both autologous and allogeneic CD4+ T cells.

Conclusions:

  • A robust assay for quantifying CD8+ T cell anti-HIV-1 activity has been established.
  • This assay is suitable for diverse sample types and conditions, facilitating widespread use.
  • The assay provides a valuable tool for monitoring antiviral responses in HIV-1 research, clinical trials, and vaccine studies.

Related Concept Videos